These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Intrapleural administration of CDDP against malignant pleural effusions in breast cancer].
    Author: Kikuchi K, Tsuyuki A, Fujishiro Y, Utsumi T, Fujisaki M, Kurihara E, Uematsu M.
    Journal: Gan To Kagaku Ryoho; 1990 Sep; 17(9):1905-8. PubMed ID: 2393307.
    Abstract:
    Malignant pleural effusion in the patients with breast cancer commonly occurs, and is a life-threatening factor. The present paper shows the usefulness of intrapleural administration of CDDP in six cases. A decrease of pleural effusions was observed in all cases. Treatment was effective in two cases of CR and four cases of PR. A median survival from initiation of intrapleural therapy is 17 months (range 2-47 months). This procedure produced distinctly fewer side effects than intravenous administration. The results of this trials suggest that CDDP should be considered as an active agent in the treatment of malignant pleural effusion in the patients with breast cancer.
    [Abstract] [Full Text] [Related] [New Search]